MADISON, Wis. — The scientist who first isolated human embryonic stem cells now hopes to profit from the discovery.
Even as the debate unfolds in Washington over federal funding for stem-cell research, Jamie Thomson and two colleagues at the University of Wisconsin-Madison have formed Cellular Dynamics International, a company that will test new drugs on heart cells they plan to develop from the undifferentiated master cells.